ES555124A0 - Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas - Google Patents
Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenasInfo
- Publication number
- ES555124A0 ES555124A0 ES555124A ES555124A ES555124A0 ES 555124 A0 ES555124 A0 ES 555124A0 ES 555124 A ES555124 A ES 555124A ES 555124 A ES555124 A ES 555124A ES 555124 A0 ES555124 A0 ES 555124A0
- Authority
- ES
- Spain
- Prior art keywords
- amino acid
- particles
- immunogenous
- procedure
- properties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title abstract 4
- 150000001413 amino acids Chemical group 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 101150010882 S gene Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8506708A FR2581394B1 (fr) | 1985-05-02 | 1985-05-02 | Particules ayant les proprietes immunogenes de l'antigene hbs et portant un site antigenique etranger aux epitopes portes par l'antigene hbs, vecteurs et cellules animales pour la production de telles particules et compositions contenant de telles particules pour la production de vaccins mixtes |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8703520A1 ES8703520A1 (es) | 1987-03-01 |
ES555124A0 true ES555124A0 (es) | 1987-03-01 |
Family
ID=9318908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES555124A Expired ES8703520A1 (es) | 1985-05-02 | 1986-05-02 | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0201416B1 (es) |
JP (2) | JPH088869B2 (es) |
AT (1) | ATE62508T1 (es) |
CA (1) | CA1282021C (es) |
DE (1) | DE3678609D1 (es) |
DK (1) | DK166357C (es) |
ES (1) | ES8703520A1 (es) |
FR (1) | FR2581394B1 (es) |
GR (1) | GR861141B (es) |
PT (1) | PT82500B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA88488B (en) * | 1987-01-30 | 1988-10-26 | Smith Kline Rit | Hepatitis b virus surface antigens and hybrid antigens containing them |
ATE207535T1 (de) * | 1987-06-22 | 2001-11-15 | Medeva Holdings Bv | Hepatitis-b-oberflächenantigen enthaltendes peptid |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
EP0491077A1 (en) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | A composition used as a therapeutic agent against chronic viral hepatic diseases |
US6740323B1 (en) | 1999-11-24 | 2004-05-25 | Chiron Corporation | HBV/HCV virus-like particle |
WO2001038358A2 (en) * | 1999-11-24 | 2001-05-31 | Chiron Corporation | Hbv/hcv virus-like particle |
JP4085231B2 (ja) | 2000-02-28 | 2008-05-14 | 株式会社ビークル | タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法 |
US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
DE60234375D1 (de) | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
JP2003286199A (ja) * | 2002-03-29 | 2003-10-07 | Japan Science & Technology Corp | タンパク質中空ナノ粒子を用いる肝臓疾患治療用薬剤 |
JP2003286198A (ja) * | 2002-03-29 | 2003-10-07 | Japan Science & Technology Corp | 増殖因子等を提示するタンパク質中空ナノ粒子を用いる治療薬剤 |
JP2003286189A (ja) * | 2002-03-29 | 2003-10-07 | Japan Science & Technology Corp | 中空ナノ粒子を形成するタンパク質に疾患治療用の細胞導入物質を融合させた薬剤 |
JP2004081210A (ja) * | 2002-06-28 | 2004-03-18 | Japan Science & Technology Corp | システイン残基を改変したタンパク質からなる中空ナノ粒子およびそれを用いた薬剤 |
DE602004008582T2 (de) | 2003-02-17 | 2008-05-21 | Peter Burkhard | Peptidische nanoteilchen als arzneimittelabgabe- und antigen-display-systeme |
EP1605972A2 (en) | 2003-03-26 | 2005-12-21 | Cytos Biotechnology AG | Hiv-peptide-carrier-conjugates |
US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
EP2766386A1 (en) | 2011-10-12 | 2014-08-20 | Alpha-o Peptides AG | Self-assembling peptide nanoparticles as vaccines against infection with norovirus |
JPWO2014103608A1 (ja) | 2012-12-25 | 2017-01-12 | 一般財団法人化学及血清療法研究所 | HPV/HBsキメラタンパク質を有効成分とするHPV感染症及び/又はB型肝炎用ワクチン |
WO2015123291A1 (en) | 2014-02-11 | 2015-08-20 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Pcsk9 vaccine and methods of using the same |
AU2018223890A1 (en) | 2017-02-23 | 2019-09-05 | Alpha-O Peptides Ag | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
EA201991918A1 (ru) | 2017-03-23 | 2020-05-15 | Альфа-О Пептидс Аг | Самосборные белковые наночастицы со встроенными белками с шестиспиральным пучком |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415491A (en) * | 1980-01-14 | 1983-11-15 | The Regents Of The University Of California | Synthetic vaccine peptide epitomes of hepatitis B surface antigen |
FR2532850B1 (fr) * | 1982-09-15 | 1985-12-20 | Pasteur Institut | Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention |
US4483793A (en) * | 1982-10-04 | 1984-11-20 | The Regents Of The University Of California | Dimeric oligopeptides as heptenic epitopic sites for hepatitis |
FR2550203B1 (fr) * | 1983-08-01 | 1985-11-22 | Anvar | Peptides synthetiques immunogenes porteurs d'un epitope caracteristique de l'antigene de surface du virus de l'hepatite b et compositions les contenant |
FR2569984B1 (fr) * | 1984-09-12 | 1987-08-14 | Anvar | Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins |
-
1985
- 1985-05-02 FR FR8506708A patent/FR2581394B1/fr not_active Expired
-
1986
- 1986-04-29 EP EP86400944A patent/EP0201416B1/fr not_active Expired - Lifetime
- 1986-04-29 DE DE8686400944T patent/DE3678609D1/de not_active Expired - Lifetime
- 1986-04-29 GR GR861141A patent/GR861141B/el unknown
- 1986-04-29 AT AT86400944T patent/ATE62508T1/de not_active IP Right Cessation
- 1986-05-02 PT PT82500A patent/PT82500B/pt not_active IP Right Cessation
- 1986-05-02 CA CA000508233A patent/CA1282021C/fr not_active Expired - Lifetime
- 1986-05-02 JP JP61102929A patent/JPH088869B2/ja not_active Expired - Lifetime
- 1986-05-02 DK DK202586A patent/DK166357C/da not_active IP Right Cessation
- 1986-05-02 ES ES555124A patent/ES8703520A1/es not_active Expired
-
1995
- 1995-07-24 JP JP7187404A patent/JPH08198897A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK166357C (da) | 1993-09-06 |
EP0201416A1 (fr) | 1986-11-12 |
JPH088869B2 (ja) | 1996-01-31 |
FR2581394B1 (fr) | 1988-08-05 |
DK202586D0 (da) | 1986-05-02 |
DE3678609D1 (de) | 1991-05-16 |
ATE62508T1 (de) | 1991-04-15 |
ES8703520A1 (es) | 1987-03-01 |
DK202586A (da) | 1986-11-03 |
EP0201416B1 (fr) | 1991-04-10 |
PT82500B (pt) | 1989-05-12 |
GR861141B (en) | 1986-08-21 |
CA1282021C (fr) | 1991-03-26 |
PT82500A (fr) | 1986-06-01 |
DK166357B (da) | 1993-04-13 |
JPS61258000A (ja) | 1986-11-15 |
JPH08198897A (ja) | 1996-08-06 |
FR2581394A1 (fr) | 1986-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES555124A0 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
CA2020668A1 (en) | Fused or hybrid protein comprising viral antigen and lymphokine | |
EP0210189A4 (en) | RECOMBINANT ALVEOLAR SURFACE ACTIVE PROTEIN. | |
AU3192889A (en) | T cell activation markers | |
DE3786649D1 (de) | Pferde-gamma-interferon. | |
ATE256182T1 (de) | Neuartiges p- selectin ligandenprotein | |
DE3586801D1 (de) | Synthetische hepatitis-b-virus-vakzine die t-zellen- und b-zellenbestimmer enthalten. | |
GR3020060T3 (en) | Modified proteins, modified interferons, alphas and beta, phosphorylated proteins and analogues, DNA sequences, applications and uses thereof | |
DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
DE3683447D1 (de) | Verfahren zur herstellung von humanlysozym. | |
ATE121754T1 (de) | Vakzine gegen bordetella. | |
GR852622B (es) | ||
EP0276778A3 (en) | High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity | |
ATE122055T1 (de) | Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung. | |
WO1987007472A3 (en) | A dna sequence encoding the mas oncogene, polypeptides encoded therefrom, and diagnostic and other methods based thereon | |
NZ233328A (en) | Polypeptides produced by hepatocytes infected with p. falciparum; nucleic acid probes | |
DE69409895D1 (de) | Zelloberflächenprotein aus brevibakterium lactofermentum | |
EP0317279A3 (en) | Peptides for use in the purification of factor viii | |
IL85759A0 (en) | The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein | |
ATE107694T1 (de) | Für a.nidulans-isopenicillin-n-synthetase codierende dns, deren verwendung und dafür codierende vektoren. | |
EP0949333A4 (en) | MUTANT ANTIGENS OF MEASURE VIRUS AND GENES ENCODING THEM | |
PT89511A (pt) | Processo para a preparacao de anfiregulina, um regulador bifuncional do crescimento de celulas | |
TH38358A (th) | ลำดับกรดนิวคลีอิคและกรดอะมิโนที่เกี่ยวข้องกับHelicobacter pylori สำหรับการวินิจฉัยและรักษา |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20000201 |